- 不限
- 2025-05-29 [星期四]
- 2025-05-30 [星期五]
- 2025-05-31 [星期六]
- 不限
- Main venue
- Sub-session 1
- Sub-session 2
- Sub-session 3
- Sub-session 4
- Meeting Room 1
2025-05-31 星期六
Sub-session 2
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 07:55-08:00 |
Speech |
Enmin Wang | Huashan Hospital, Fudan University |
| 2 | 08:00-08:20 |
Radiosurgery for Benign CNS Tumors: Common and Uncommon Indications |
Jung IL Lee | Samsung Medical Center Sungkyunkwan University School of Medicine |
| 3 | 08:20-08:40 |
A North American Clinical Trials Network (NCTN) randomized trial of radiosurgery vs. hippocampal avoidant whole-brain radiotherapy for patients with 5 or more brain metastases — an update of CCTG CE.7 |
David Roberge | CCTG/CHUM |
| 4 | 08:40-09:00 |
The Application of AI in SRS for Brain Metastases |
Wenyin Shi | Thomas Jefferson University |
| 5 | 09:00-09:15 |
Gamma Knife Radiosurgery for Intracranial Solitary Fibrous Tumor in Tiantan hospital |
Shibin Sun | Beijing Tiantan Hospital, Capital Medical University |
| 6 | 09:15-09:30 |
Cyberknife Radiosurgery for Glioblastoma: Present Clinical Practice and Future Studies |
Xin Wang | Huashan Hospital, Fudan University |
| 7 | 09:30-09:45 |
The Profile of Microenvironment Alterations Induced by Carbon Ion Radiation in Glioblastoma |
Ying Wang | Sun Yat-sen University Cancer Center |
| 8 | 09:45-10:00 |
Staged Gamma Knife Radiosurgery for Complex Cavernous Sinus Hemangiomas：10-year Experience at a High-volume Center |
xuqun tang | Shanghai Gamma Hospital |
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 10:20-10:40 |
Exploring the Repetitive Genome Uncovers Novel Insights into Medulloblastoma Development |
Hiromichi Suzuki | National Cancer Center Research Institute (Japan) |
| 2 | 10:40-10:55 |
Preliminary Outcomes of TTFields Therapy in Treating Supratentorial H3 Histone-Variant Gliomas |
Xianxin Qiu | Huashan Hospital, Fudan University |
| 3 | 10:55-11:10 |
Nimotuzumab combined with chemoradiotherapy in newly diagnosed pediatric diffuse intrinsic pontine glioma. |
Yanwei Liu | Beijing Tiantan Hospital, Capital Medical University |
| 4 | 11:10-11:22 |
Histogram Analysis of IVIM MRI for Differentiating Glioma IDH-1 Status, Grade, and Ki-67 Expression: A Comparison of Bi-Exponential Models at Multiple B-Value |
Yifei Su | Shanxi Provincial People's Hospital |
| 5 | 11:22-11:34 |
Results of the combination of stereotactic radiotherapy with surgical resection in the local treatment of brain metastases |
Pavel Fadrus | Department of Neurosurgery, University Hospital Brno |
| 6 | 11:34-11:46 |
Treg-driven magnetic resonance radiomics in glioblastoma: a multi-center and cross-species model for prognostic biomarker discoveryTreg |
Mingwei Zhang | The First Affiliated Hospital of Fujian Medical University |
| 7 | 11:46-12:00 |
Discussion & Summarize |
||
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 13:00-13:10 |
Welcome Speech |
Yonggao Mou | Sun Yat-sen University Cancer Center |
| 2 | 13:10-13:35 |
The Dawn of Glioma Clinical Trials in China |
Wei Hua | Huashan Hospital, Fudan University |
| 3 | 13:35-13:50 |
TAC-GReD trial Combination talazoparib – carboplatin for recurrent high grade glioma with DNA damage repair deficiency Phase II, single arm study |
Aya El Helali | Hong Kong University School of Clinical Medicine |
| 4 | 13:50-14:05 |
Construction of Research-Oriented Wards and Clinical Trials for Brain Tumors |
Wenbin Li | Beijing Tiantan Hospital, Capital Medical University |
| 5 | 14:05-14:20 |
Clinical Trials at Sun Yat-Sen University Cancer Center |
Chengcheng Guo | Sun Yat-sen University Cancer Center |
| 6 | 14:20-14:35 |
Transforming Glioma Surgery With Cellular Presicion |
Xiang Zou | HuaShan Hospital, Fudan University |
| 7 | 14:35-14:50 |
Investigator-Initiated Trial of Fourth-Generation Dual-Target Optimized Tris-CAR-T Cell Intratumoral Injection Therapy for Recurrent Glioblastoma |
Wei Zhang | Beijing Tiantan Hospital ，Capital Medical University |
| 8 | 14:50-15:05 |
MR-Linac-Guided Adaptive Radiotherapy for HGG: Retrospective Analysis of Therapeutic Outcomes with Concurrent Chemoradiotherapy Integrated with TTFields |
Mengqi Sun | Shenzhen People’s Hospital |
| 9 | 15:05-15:20 |
Results and status of Japanese clinical trials |
Yoshiki Arakawa | Kyoto University Graduate school of Medicine |
| 编号 | 时间 | 题目 | 讲者 | 单位 |
|---|---|---|---|---|
| 1 | 15:30-15:40 |
A Phase 1/2a clinical trial of A-BNCT in patients with recurrent high grade glioma in Korea |
Gi-Taek Yee | Gachon university, Gil medical center |
| 2 | 15:40-15:50 |
Clinical Trials of Pituitary Tumors at Huashan Hospital |
Nidan Qiao | Huashan Hospital ，Fudan University |
| 3 | 15:50-16:00 |
Clinical Safety Study of a Novel Anti-FAP CAR-T Cell Therapy Based on CTLA-4 Nanobody for Advanced Glioma |
Xuan Wang | Wuhan Union Hospital |
| 4 | 16:00-16:10 |
Protocol on the Safety of BGC515 in the Treatment of Recurrent Glioblastoma |
Xinru Xiao | Xuanwu Hospital, Capital Medical University |
| 5 | 16:10-16:20 |
Super-selective Intra-arterial Chemotherapy Combined with Tumor-feeding Artery Embolization for Glioblastoma：A Prospective Clinical Study |
Xingwang Zhou | The Affiliated Hospital of Guizhou MedicalUniversity |
| 6 | 16:20-16:30 |
Multi-Modal Deep Learning-Based Craniopharyngioma Diagnosis and Treatment Report Generation and Short- to Mid-Term Prognosis Prediction Model |
Xiaorong Yan | The First Affiliated Hospital of Fujian Medical University |
| 7 | 16:30-16:40 |
Exploratory Clinical Study on the Feasibility, Safety, and Efficacy of Ultrasound-Induced Nuclear Resonance Therapy for Glioblastoma |
Junhao Zhu | Jinling Hospital ，Medical School of Nanjing University |
| 8 | 16:40-16:50 |
Combined Dopamine Agonist and Hydroxychloroquine Therapy for Resistant Prolactinoma: Initial Efficacy Analysis |
Shaojian Lin | Ruijin Hospital, Shanghai Jiao Tong University School of Medicine |
| 9 | 16:50-17:00 |
Discussion & Summarize |
||
美迪康会务通